Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (290) Mirapex, Pharmacia & Upjohn, Boehringer Ingelheim,
...Mirapex (pramipexole) is the first Parkinson’s agent approved by the FDA since Somerset’s monoamine oxidase inhibitor Eldepryl in 1989. Mirapex, a non-ergot D3 dopamine agonist, is approved for the ...
View Page

2.  Newly Approved Drug Therapies (461) Celexa, Forest Laboratories,
...sleepiness. Additional Information Precautions: As with others SSRIs, Celexa should not be taken together with monoamine oxidase inhibitors. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC. Designed by ...
View Page

3.  Study Posting (5306) Trial #154158, Depression (Adolescent), Riverside, CA
...a history of electroconvulsive therapy with 1 year of visit 1. • Have had treatment of monoamine oxidase inhibitor (MAOI) with 14 days or fluoxetine with 30 day of visit 3. • Have been ...
View Page

4.  Newly Approved Drug Therapies (734) Focalin (dexmethylphenidate HCl), Celgene,
...to be hypersensitive to the drug. It also should not be used during treatment with monoamine oxidase inhibitors, or within a minimum of 14 days following discontinuation of a monoamine oxidase inhibitor ...
View Page

5.  Study Posting (1918) Trial #159850, Prostate Cancer, Savannah, GA
...Exclusion Criteria : PRIOR CONCURRENT THERAPY : • See Disease Characteristics • More than 14 days since prior venlafaxine, monoamine oxidase inhibitor (MAOI), selective serotonin reuptake inhibitor (SSRI), or selective norepinephrine reuptake inhibitor (SNRI) • No concurrent ...
View Page

6.  Study Posting (1918) Trial #159849, Hot Flash, Savannah, GA
...Exclusion Criteria : PRIOR CONCURRENT THERAPY : • See Disease Characteristics • More than 14 days since prior venlafaxine, monoamine oxidase inhibitor (MAOI), selective serotonin reuptake inhibitor (SSRI), or selective norepinephrine reuptake inhibitor (SNRI) • No concurrent ...
View Page

7.  Newly Approved Drug Therapies (261) Zyban Sustained-Release Tablets, GlaxoSmithKline,
...should also not be used in people who are taking or have recently taken a monoamine oxidase inhibitor (MAOI). Zyban should not be used in patients with a seizure disorder who have ...
View Page

8.  Newly Approved Drug Therapies (637) Concerta, Alza,
...marked anxiety or agitation, glaucoma, or tics. It is also contraindicated during any treatment with monoamine oxidase inhibitors. Mechanism of Action Concerta uses osmotic pressure to deliver methylphenidate HCl at a controlled ...
View Page

9.  Newly Approved Drug Therapies (663) Remeron SolTab (mirtazapine), Organon,
...unknown. Mirtazapine has a tetracyclic chemical structure unrelated to selective serotonin reuptake inhibitors, tricyclics or monoamine oxidase inhibitors (MAOI). It belongs to the piperazino-azepine group of compounds. According to preclinical studies ...
View Page

10.  Study Posting (4265) Trial #163387, Alcohol Dependence, West Palm Beach, FL
...s ability to complete the study • Current need for antidepressants including, but not limited to, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), and/or lithium Miriam Trelka, Clinical ...
View Page

11.  Study Posting (1918) Trial #159190, Solid Tumors, Savannah, GA
...radiotherapy allowed • Surgery Not specified • Other At least 2 weeks since prior and no concurrent monoamine oxidase inhibitors (MAOIs) • Concurrent narcotic medications allowed • Concurrent benzodiazepine medications allowed • Concurrent serotonin reuptake inhibitors allowed ...
View Page